Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study

…, SK Bonkat, J Geday, M Otto, M Sommerauer… - Brain, 2020 - academic.oup.com
Parkinson’s disease is characterized by the presence of abnormal, intraneuronal α-synuclein
aggregates, which may propagate from cell-to-cell in a prion-like manner. However, it …

In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study

…, TD Fedorova, AK Hansen, M Sommerauer… - The Lancet …, 2018 - thelancet.com
Background Accumulating evidence suggests that α-synuclein aggregates—a defining
pathology of Parkinson's disease—display cell-to-cell transmission. α-synuclein aggregation is …

PET imaging in patients with meningioma—report of the RANO/PET Group

N Galldiks, NL Albert, M Sommerauer, AL Grosu… - Neuro …, 2017 - academic.oup.com
Meningiomas are the most frequent nonglial primary brain tumors and represent about 30%
of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging …

Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease

…, DJ Brooks, A Nahimi, P Borghammer, M Sommerauer - Brain, 2021 - academic.oup.com
… Per Borghammer and Michael Sommerauer authors contributed equally to this work. … Adjmal
Nahimi, Per Borghammer, Michael Sommerauer, Regional locus coeruleus degeneration is …

Separation of 2 (3), 9 (10), 16 (17), 23 (24)-tetrasubstituted phthalocyanines with newly developed HPLC phases

M Sommerauer, C Rager, M Hanack - Journal of the American …, 1996 - ACS Publications
The synthesis of 2(3),9(10),16(17),23(24)-tetrasubstituted phthalocyanines from 1,2-dicyano-4-alkoxybenzenes
or the corresponding isoindolines is reported. In each case, four isomers …

Excessive sleep need following traumatic brain injury: a case–control study of 36 patients

M Sommerauer, PO Valko, E Werth… - Journal of sleep …, 2013 - Wiley Online Library
Increased sleep need following traumatic brain injury, referred to in this study as post‐traumatic
pleiosomnia, is common, but so far its clinical impact and therapeutic implications have …

[HTML][HTML] Clinical and imaging evidence of brain-first and body-first Parkinson's disease

J Horsager, K Knudsen, M Sommerauer - Neurobiology of disease, 2022 - Elsevier
Braak's hypothesis has been extremely influential over the last two decades. However,
neuropathological and clinical evidence suggest that the model does not conform to all patients …

Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study

M Sommerauer, TD Fedorova, AK Hansen, K Knudsen… - Brain, 2018 - academic.oup.com
Pathological involvement of the noradrenergic locus coeruleus occurs early in Parkinson’s
disease, and widespread noradrenaline reductions are found at post-mortem. Rapid eye …

Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake

…, A Pangalu, M Weller, JC Tonn, M Sommerauer… - Neuro …, 2016 - academic.oup.com
Background The prognosis of patients with progressive meningioma after failure of surgery
and radiotherapy is poor. Methods We retrospectively evaluated the safety and efficacy of …

68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?

M Sommerauer, JK Burkhardt, K Frontzek… - Neuro …, 2016 - academic.oup.com
Background DOTATATE-based radionuclides have added new options in the diagnosis and
treatment of meningiomas; however, a reliable predictor of tumor growth has still not been …